March 26, 2021
March 26, 2021 – The U.S. FDA has approved Abecma (idecabtagene vicleucel), manufactured by Bristol Myers Squibb and bluebird bio, Inc., to treat relapsed or refractory multiple
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
Global Reach Health
March 25, 2021
March 25, 2021 – The U.S. FDA has issued a warning that abuse and misuse of nasal decongestant propylhexedrine, an over-the-counter (OTC) product sold under the brand
March 25, 2021
March 25, 2021 – The U.S. FDA is requiring an update to the prescribing information for
GlaxoSmithKline’s Shingrix® (zoster vaccine recombinant, adjuvanted)
March 25, 2021
March 25, 2021 – Zydus Pharmaceuticals has voluntarily recalled four lots of Acyclovir Sodium Injection, 50mg/mL, 10mL and 20mL vials, after receiving complaints
March 25, 2021
March 25, 2021 – The U.S. FDA has approved a new indication for Astellas Pharma's
Myrbetriq® (mirabegron extended-release tablets) and Myrbetriq® Granules
March 24, 2021
March 24, 2021 – Alembic Pharmaceuticals has voluntarily recalled a single lot of Telmisartan Tablets, USP, 20mg, packaged in 30-count bottles. The recall is due to a customer
March 23, 2021
March 23, 2021 – The U.S. FDA has approved a new indication for Keytruda® (pembrolizumab),
manufactured by Merck. The drug is now indicated for use in combination
March 22, 2021
March 22, 2021 – The U.S. FDA has approved Zegalogue® (dasiglucagon), manufactured by Zealand
Pharmaceuticals, to treat severe hypoglycemia (low blood sugar) in patients who